Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo

Hayashibara Co., Ltd.

Seibutsu Kagaku Kenkyujo

Kabushiki Kaisha Hayashibara

Other

Kabushiki Kaisha Hayashibara Seibutsu

Kanpe Katei Toryoo Kabushiki Kaisha

Kanebo, Limited

501 Kabushiki Kaisha Hayashibara Kagaku Kenkyujo

Ensuiko Seito Kabushiki Kaisha

Kabushiki Kaisha Hayahibara

Kabushiki Kaisha Hoyashibara

Kanpe Katei Toriyoo K.k.

K.k. Hayashibara Seibutsu Kagaku Yufo

Hayashibara Seibutsu Kagaku Kenkyujo Kabushiki Kaisha

Toshio Miyake

Toshiyuki Sugimoto

Hiroto Chaen

Michio Kubota

Shigeharu Fukuda

Takashi Shibuya

Tomoyuki Nishimoto

Shuzo Sakai

Masakazu Mitsuhashi

Satoshi Iritani

Kazuhiko Maruta

Hajime Aga

Masaru Yoneyama

Hiromi Hijiya

Kazuyuki Oku

Tetsuya Nakada

Takahiko Mandai

Hikaru Masahiro Watanabe

Seisuke Izawa

Masayuki Nakano

Kazuhisa Mukai

Keiji Tsusaki

Katsumi Hirao

Takanobu Higashiyama

Yoshinori Sato

Yukio Uchida

Itaru Yamamoto

Takuo Yamamoto

Norio Muto

Yukio Suzuki

Kei Suzuki

Tetsuya Ohashi

Yasuo Takeuchi

Naohiko Katagiri

Shinji Suzuki

Kozo Hara

Masayuki Yamashita

Teruo Matsumoto

Takanori Okura

Naoko Yamashita

Tatsuo Nomura

Katsuhiko Hino

Takashi Yumoto

Yoshihide Ozaki

Satoshi Nakamura

Katsuhide Okada

Kyoichi Otsu

Yasuhiko Tsunetomi

Yoshiji Okumura

Shouji Ikegami

Kohki Fujita

Hikaru Watanabe

Kaname Sugimoto

Yoshiaki Sone

Akira Misaki

Takeshi Ario

Yoshikatsu Miwa

Shunsaku Koyama

Shoichi Hamada

Koichi Nishi

Mikihiko Yoshida

Kanou Takeuchi

Tetsushi Ishikawa

Masatoshi Manabe

Tohru Miyaaki

Toshiharu Hanaya

Mayumi Kurose

Tomohiko Sonoda

Shoichi Ohno

Masao Maeda

Michiyo Fukuse

Hiroshi Akai

Michihiro Kohguchi

Kenshi Yoshida

Kano Takeuchi

Ikuo Sawatani

Hitomi Ohta

Shoich Hamada

Hideki Fukushima

Takashi Ohtsuki

Fujimi Tanabe

Hiromi Tatsukawa

Akihiko Tabuchi

Hiroshi Yamasaki

The invention provides a process for enabling the production of a particulate composition containing anhydrous crystalline ascorbic acid 2-glucoside that does not significantly cake even when the production yield of ascorbic acid 2-glucoside does not reach 35% by weight. The process for producing a particulate composition containing anhydrous crystalline ascorbic acid 2-glucoside, which comprises allowing a CGTase to act on a solution containing either liquefied starch or dextrin and L-ascorbic acid and then allowing a glucoamylase to act on the resulting solution to obtain a solution with an ascorbic acid 2-glucoside production yield of at least 27%, purifying the obtained solution to increase the ascorbic acid 2-glucoside content to a level of over 86% by weight, precipitating anhydrous crystalline ascorbic acid 2-glucoside by a controlled cooling method or pseudo-controlled cooling method, collecting the precipitated anhydrous crystalline ascorbic acid 2-glucoside, and ageing and drying the collected anhydrous crystalline ascorbic acid 2-glucoside.

Process for producing a particulate composition comprising an hydrous crystalline 2-o-alpha-d-glucosyl-ascorbic acid

Process for producing a particulate composition comprising an hydrous crystalline 2-O-&#x3b1;-D-glucosyl-L-ascorbic acid

Process for producing a particulate composition comprising anhydrous crystalline 2-O-alpha-D-glucosyl-L-ascorbic acid

The objects of the present invention are to provide a method for inhibiting the coloration of a syrupy sweetener, comprising a reducing saccharide together with a non-reducing oligosaccharide having a &#x3b2;-fructofuranosidic linkage, without deteriorating the taste inherent to the syrupy sweetener; and to provide a syrupy sweetener, comprising a reducing saccharide together with a non-reducing oligosaccharide having a &#x3b2;-fructofuranosidic linkage, which is stabilized by the method. The present invention attains the above objects by providing a method for inhibiting the coloring of a syrupy sweetener, comprising a reducing saccharide together with a non-reducing oligosaccharide having a &#x3b2;-fructofuranosidic linkage, which comprises a step of incorporating a lactate into the syrupy sweetener, and by providing a syrupy sweetener, comprising a reducing saccharide together with a non-reducing oligosaccharide having a &#x3b2;-fructofuranosidic linkage, which is stabilized by the method.

Method for inhibiting coloring of a syrupy sweetener comprising a non-reducing oligosaccharide having a beta-fructofranosidic linkage and a reducing saccharide, and use thereof

The present invention has an object to provide a fluid for peritoneal dialysis with satisfactory body fluid removability, high biocompatibility, and improved storage stability, and the object is attained by a fluid for peritoneal dialysis containing one or more saccharides selected from cyclonigerosylnigerose, cyclomaltosylmaltose, and L-ascorbic acid 2-glucoside.

Fluid for peritoneal dialysis

The object of the present invention is to provide a lipid-regulating agent or a composition for regulating the amount of lipids comprising the agent. The present invention solves the above object by providing a lipid-regulating agent comprising a cyclic tetrasaccharide and/or its saccharide-derivative(s) and a composition for regulating the amount of lipids comprising the lipid-regulating agent.

Lipid-regulating agent and use thereof

An object of the present invention is to provide a method for inhibiting the deterioration of eating-quality characteristics of a food containing gelatinized starch and to keep their eating-quality characteristics as just prepared after a relatively prolonged storage under freezing, refrigerating, chilling or room temperature. The present invention achieves the above object by a method of permeating of maltose and/or &#x3b1;,&#x3b1;-trehalose or saccharides comprising the same and other oligosaccharides in a prescribed ratio into the above food containing gelatinized starch by admixing the saccharide to the food and holding them at relatively high temperature for a prescribed period.

Method for inhibiting the deterioration of eating-quality characteristics of foods containing gelatinized starch

The object of the present invention is to overcome conventional demerits of pullulan powders prepared by conventional techniques, i.e., they could not be homogeneously mixed with non-reducing saccharides composed of glucose units when mixed together, and the resulting mixtures do not easily dissolve in water; and to provide a pullulan-containing powder with an improved rate of water dissolution, as well as to provide preparations and uses thereof. The present invention solves the above object by providing a pullulan-containing powder which uniformly comprises pullulan as a main ingredient and a non-reducing saccharide, and their process and uses; wherein the pullulan-containing powder is prepared by the steps of preparing a solution dissolving pullulan and a non-reducing saccharide homogeneously, pulverizing the solution, and collecting the resulting pullulan-containing powder. The powder has an improved rate of water dissolution, while retaining satisfactory resistance to humidity without fear of causing separation between the pullulan and the non-reducing saccharide.

Pullulan-containing powder, process for producing the same and use thereof

The present invention aims to provide a particulate composition containing anhydrous crystalline 2-O-&#x3b1;-D-glucosyl-L-ascorbic acid having a significantly, hardly solidifiable property compared to conventional ones in a grade for use in quasi-drugs; a process for producing the same; and uses thereof. The present invention solves the above object by providing a particulate composition containing anhydrous crystalline 2-O-&#x3b1;-D-glucosyl-L-ascorbic in an amount of over 98.0% by weight but less than 99.9% by weight, on a dry solid basis; or a degree of crystallinity of 90% or higher for anhydrous crystalline 2-O-&#x3b1;-D-glucosyl-L-ascorbic acid; and by providing a process for producing the same and uses thereof.

Particulate composition containing anhydrous crystalline 2-O-alpha-D-glucosyl-L-ascorbic acid, process for producing the same, and uses thereof

The object of the present invention is to provide a method and a process for producing 2-O-&#x3b1;-glucopyranosyl-L-ascorbic acid where 5-O-&#x3b1;-glucopyranosyl-L-ascorbic acid and 6-O-&#x3b1;-glucopyranosyl-L-ascorbic acid are not formed or formed in such a small amount that the formation of these can nor be detected. The present invention solves the above object by providing a process for producing 2-O-&#x3b1;-glucopyranosyl-L-ascorbic acid comprising the steps of allowing &#x3b1;-isomaltosyl glucosaccharide-forming enzyme together with or without cyclomaltodextrin glucanotransferase (EC 2.4.1.19) to act on a solution comprising L-ascorbic acid and, an &#x3b1;-glucosyl saccharide to form 2-O-&#x3b1;-glucopyranosyl-L-ascorbic acid and collecting the formed 2-O-&#x3b1;-glucopyranosyl-L-ascorbic acid.

Process for producing 2-O-alpha-D-glucopyranosyl-L-ascorbic acid

The present invention has objects to provide a method for inhibiting the formation of volatile aldehydes and/or the decomposition of fatty acids and use thereof. These objects are attained by establishing a method which comprises incorporating an &#x3b1;-oligoglucosyl &#x3b1;,&#x3b1;-trehalose(s) to a target product to inhibit the formation of volatile aldehydes per se and/or the decomposition of fatty acids per se in fatty acid-containing products; an inhibitory agent for inhibiting the formation of volatile aldehydes and/or the decomposition of fatty acids, which contains an &#x3b1;-oligoglucosyl &#x3b1;,&#x3b1;-trehalose(s) as an effective ingredient; and use thereof to thereby obtain various compositions such as food products, cosmetics, pharmaceuticals, and their materials and intermediates each having a high quality and stability.

Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof

A non-reducing saccharide by providing a novel non-reducing saccharide composed of glucose as constituents, a novel enzyme forming the non-reducing saccharide, a method and process for producing the same, a DNA encoding the enzyme, a recombinant DNA and transformant comprising the DNA, a composition comprising the non-reducing saccharide, and uses thereof are provided by use of an isocyclomaltooligosaccharide(s) having a structure represented by Formula 1,Cyclo{&#x2192;6)-[&#x3b1;-D-Glcp-(1&#x2192;4)]-&#x3b1;-D-Glcp-(1&#x2192;}, wherein 'is 4 or 5.

Isocyclomaltooligosaccharide(s), isocyclomaltooligosaccharide-forming enzyme, their preparation and uses

An object of the present invention is to provide a novel starchy substance having a retrogradation-resistance, a process for producing the starchy substance efficiently from a material starch by enzymatic reaction, and uses thereof. The present invention attains the above object by providing branched starch having 6-&#x3b1;-maltosyl- and/or 6-&#x3b1;-maltotetraosyl-structure(s) with a marked retrogradation-resistance, a process for producing the branched starch without lowering the molecular weight of material starch, and uses thereof.

Highly-branched starch, its production and uses

The object of the present invention is to establish a volatile sulfide production inhibitor that can inhibit the production of volatile sulfides from a composition and to provide a method for inhibiting the production of volatile sulfides from a composition by using the inhibitor. The object are solved by providing a volatile sulfide production inhibitor comprising L-ascorbic acid 2-glucoside as an effective ingredient and a method for inhibiting the production of volatile sulfides from a composition by incorporating the volatile sulfide production inhibitor into the composition.

Volatile sulfide production inhibitor and method for inhibiting the production of volatile sulfide using the inhibitor

Growing community of inventors

Okayama, Japan

Toshio Miyake